If you take a GLP-1 medication, you've probably asked yourself whether a stomach ache or a wave of dizziness is the drug settling in or something that needs a doctor now. Most searches for GLP-1 warning signs return long lists that treat every symptom as equally alarming, and that doesn't help much. Nausea, abdominal discomfort, and weakness are common in the first weeks of treatment, so a single symptom rarely tells you how fast to act.
Intensity, duration, and pattern usually matter more. A mild cramp that fades after a meal tells a different story than pain that builds for hours and pushes toward your back. This post sorts symptoms into three levels: urgent care now, a call to your prescriber the same day, or a note for your next appointment. It won't give you a diagnosis. Nobody can diagnose you from a blog post. The guide only helps you decide how quickly to reach out.
The prescribing information for your specific product is the reference that counts most. The Boxed Warning and Warnings and Precautions sections of the labels for semaglutide products such as Ozempic and Wegovy, and for tirzepatide products such as Mounjaro and Zepbound, are the documents your doctor will check. You can read the U.S. versions on DailyMed and the Brazilian bula in Anvisa's Bulário Eletrônico. Use general information like this to prepare for the conversation, not to replace it.
Details fade quickly by the time you sit down with a clinician. Writing down dates, times, and doses, on paper or in an app like PeptPro, turns vague feelings into facts your doctor can use.